Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.
Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision metadata updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedAdded a note indicating that publications are automatically filled from PubMed and may not all relate to the study. Updated the page revision to v3.3.1.SummaryDifference0.1%
- Check29 days agoChange DetectedThe page no longer displays the government funding status notice; this change does not affect the study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check43 days agoChange DetectedTwo screenshots show only minor UI/layout updates and updated timestamps. Core study content, including eligibility criteria, outcomes, and Pembrolizumab intervention, appears unchanged.SummaryDifference0.4%
- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%
- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.